EUCI — Eurocine Vaccines AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK22.39m
- SEK21.08m
Annual balance sheet for Eurocine Vaccines AB, fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.95 | 13.9 | 13.9 | 14.2 | 1.04 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.458 | 21.9 | 21.9 | 4.56 | 4.53 |
| Total Current Assets | 5.41 | 35.8 | 35.8 | 18.8 | 5.57 |
| Total Assets | 5.41 | 35.8 | 35.8 | 18.8 | 5.57 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 2.02 | 3.85 | 3.85 | 3.21 | 2.36 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.02 | 3.85 | 3.85 | 3.21 | 2.36 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3.39 | 31.9 | 31.9 | 15.6 | 3.21 |
| Total Liabilities & Shareholders' Equity | 5.41 | 35.8 | 35.8 | 18.8 | 5.57 |
| Total Common Shares Outstanding |